Legato Capital Management’s Guardian Pharmacy Services GRDN Stock Holding History

Legato Capital Management’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.22M	Buy	+58,890	New	+$1.92M	0.2%	154

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Legato Capital Management's GRDN Position: Q1 2026 in Review

Legato Capital Management opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 58,890 shares worth $2.22M. The stake represents 0.2% of the portfolio and ranks #154 among its holdings.

171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

Legato Capital Management held 58,890 shares of Guardian Pharmacy Services worth $2.22M as of Q1 2026.
Guardian Pharmacy Services was a new Legato Capital Management position in Q1 2026.
Guardian Pharmacy Services made up 0.2% of Legato Capital Management's portfolio in Q1 2026, its #154 holding.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.